Abstract
Diabetic retinopathy (DR) is the leading cause of visual loss in people aged 30 to 69 years. Most authorities recommend screening of the ocular fundus to prevent severe visual loss. The increasing incidence of diabetes mellitus and fewer ophthalmologists in many countries is leading to inadequate screening. Establishing an adequate system for DR screening is a complex issue and represents a challenge for most health authorities. To alleviate the burden of DR screening for most health systems, some investigators have suggested that general practitioners (GPs) perform the initial screenings. The aim of this article was to review the current status of DR screening performed by GPs using non-mydriatic retinography. The five studies analyzed in this review indicated that after adequate training GPs can be effective and reliable screeners of DR using non-mydriatic retinography. Including GPs in the screening model would be a useful way to alleviate the increasing demands of ophthalmic care resulting from the increased prevalence of diabetes mellitus. In addition, GPs would have full control of the diabetic process, which could bolster their motivation and confidence in other areas of diabetes care and medical practice.
Keywords: Diabetic retinopathy screening, General practitioners, Non-mydriatic retinography
Current Diabetes Reviews
Title:Diabetic Retinopathy Screening by General Practitioners Using Non- Mydriatic Retinography
Volume: 9 Issue: 1
Author(s): Mónica Perez-de-Arcelus, Jose Andonegui, Luis Serrano, Aitor Eguzkiza and Jose Ramon Maya
Affiliation:
Keywords: Diabetic retinopathy screening, General practitioners, Non-mydriatic retinography
Abstract: Diabetic retinopathy (DR) is the leading cause of visual loss in people aged 30 to 69 years. Most authorities recommend screening of the ocular fundus to prevent severe visual loss. The increasing incidence of diabetes mellitus and fewer ophthalmologists in many countries is leading to inadequate screening. Establishing an adequate system for DR screening is a complex issue and represents a challenge for most health authorities. To alleviate the burden of DR screening for most health systems, some investigators have suggested that general practitioners (GPs) perform the initial screenings. The aim of this article was to review the current status of DR screening performed by GPs using non-mydriatic retinography. The five studies analyzed in this review indicated that after adequate training GPs can be effective and reliable screeners of DR using non-mydriatic retinography. Including GPs in the screening model would be a useful way to alleviate the increasing demands of ophthalmic care resulting from the increased prevalence of diabetes mellitus. In addition, GPs would have full control of the diabetic process, which could bolster their motivation and confidence in other areas of diabetes care and medical practice.
Export Options
About this article
Cite this article as:
Perez-de-Arcelus Mónica, Andonegui Jose, Serrano Luis, Eguzkiza Aitor and Ramon Maya Jose, Diabetic Retinopathy Screening by General Practitioners Using Non- Mydriatic Retinography, Current Diabetes Reviews 2013; 9 (1) . https://dx.doi.org/10.2174/1573399811309010002
DOI https://dx.doi.org/10.2174/1573399811309010002 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mucoadhesive Propolis Gel for Prevention of Radiation-Induced Oral Mucositis
Current Clinical Pharmacology Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
Current Drug Targets Recent Advances in the Medicinal Chemistry of Aurones
Current Medicinal Chemistry Why Antidiabetic Vanadium Complexes are Not in the Pipeline of “Big Pharma” Drug Research? A Critical Review
Current Medicinal Chemistry Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer’s Disease
Current Neurovascular Research Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Glycaemic Control: A Balancing Act or A Different Approach?
Current Diabetes Reviews Anti-VEGF Molecules for the Management of Diabetic Macular Edema
Current Pharmaceutical Design Myocardial Revascularization for the Elderly: Current Options, Role of Off-pump Coronary Artery Bypass Grafting and Outcomes
Current Cardiology Reviews The Follow-Up of Dietary Treatment of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review
Current Stem Cell Research & Therapy A Novel Monocyte-based Pyrogen Test Based on the Mechanism of Human Fever Reaction
Current Pharmaceutical Analysis Linezolid in Children: Recent Patents and Advances
Recent Patents on Anti-Infective Drug Discovery Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews Autism: Pathophysiology and Promising Herbal Remedies
Current Pharmaceutical Design Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus
Current Topics in Medicinal Chemistry Flow Cytometry Study of Leukocyte Function: Analytical Comparison of Methods and their Applicability to Clinical Research
Current Medicinal Chemistry Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design